TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.

Christina A Muzny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.